There’s nothing better than a marriage built on the bond of profit potential.
Take TruBrain’s venture into the CBD vertical. They’re taking their high-performance cognitive nutrition brand…which has already amassed a lifetime sales total to the tune of roughly $12M… and adding a line of CBD infused products that could prove to be a match made in heaven.
Having already established itself as a heavy hitter in the cognitive nutrition space, they’re ready to tackle the booming CBD market, a move they believe could catapult them to $100M in revenue.
The Future of TruBrain
TruBrain has its sights on becoming the next iconic nutrition brand. They seek to follow the model set by such brands as RX Bar and EAS Sports Nutrition, which saw successful exits for $600M+ and $320M+ respectively.
What Interested Investors Need to Know
Three things that investors should take note of:
- Unique product offering: TruBrain is pioneering the combination of CBD, Nootropics, and Ketones with their new, patent-pending product line.
- Building on success: TruBrain has already raised $1.6M in Venture funds and is ready to keep that train rolling with this equity raise.
- The trifecta of hot markets: Nootropics, Ketones, and CBD will represent $38B+ in combined estimated market potential by 2024.